Latest Articles

Publication Date
Young West Lothian mum 'took her own life while waiting in agony for endometriosis surgery' - Edinburgh Live

Young West Lothian mum 'took her own life while waiting in agony for endometriosis surgery' Edinburgh Live

Published: July 16, 2026, 6:05 a.m.
Onconic's Nesuparib Targets 26 Trillion Won Endometrial Cancer Market, Backed by SCI Paper - Seoul Economic Daily

Onconic's Nesuparib Targets 26 Trillion Won Endometrial Cancer Market, Backed by SCI Paper Seoul Economic Daily

Published: July 16, 2026, 5:33 a.m.
A Vancouver Teen’s Mission to Bring Endometriosis Education to Schools - The Tyee

A Vancouver Teen’s Mission to Bring Endometriosis Education to Schools The Tyee

Published: July 16, 2026, 4:19 a.m.
"My daughter died in endometriosis agony - we need change to protect women" Grieving mum hits out over care - Daily Record

"My daughter died in endometriosis agony - we need change to protect women" Grieving mum hits out over care Daily Record

Published: July 16, 2026, 3:32 a.m.
Oriva: Targeting the endometriosis trifecta - biocentury.com

Oriva: Targeting the endometriosis trifecta biocentury.com

Published: July 16, 2026, 12:14 a.m.
Oriva: Targeting the endometriosis trifecta - BioCentury

Oriva: Targeting the endometriosis trifecta BioCentury

Published: July 16, 2026, 12:14 a.m.
Merck's (MRK) Keytruda Becomes First PD-1 Inhibitor To Beat Chemotherapy Alone In Endometrial Cancer Subtype - londoninsider.co.uk

Merck's (MRK) Keytruda Becomes First PD-1 Inhibitor To Beat Chemotherapy Alone In Endometrial Cancer Subtype londoninsider.co.uk

Published: July 15, 2026, 11:49 p.m.
Leven Rambin reveals life-threatening surgery complication after endometriosis procedure - MSN

Leven Rambin reveals life-threatening surgery complication after endometriosis procedure MSN

Published: July 15, 2026, 9:13 p.m.
The many potential symptoms of endometriosis - Contemporary OB/GYN

The many potential symptoms of endometriosis Contemporary OB/GYN

Published: July 15, 2026, 8 p.m.
Merck touts Keytruda front-line win in endometrial cancer subtype, marking a PD-1 first - Fierce Pharma

Merck touts Keytruda front-line win in endometrial cancer subtype, marking a PD-1 first Fierce Pharma

Published: July 15, 2026, 7:33 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!